Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Feed Symbols: CVS

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Options

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights
January 24, 2:47 PM
  During Tuesday, 17 stocks hit new 52-week lows.

BMRC

Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • Media
  • News
  • Penny Stocks

Rite Aid Starts Selling Abortion Medication From Few Pharmacies: Report

By Vandana Singh
January 20, 7:57 AM
Rite Aid Corp (NYSE: RAD) plans to dispense abortion pill mifepristone in a limited number of its pharmacies and will serve customers in person or through mail delivery.

CVS

Read More
2 minute read
  • Analyst Ratings

What 11 Analyst Ratings Have To Say About CVS Health

By Benzinga Insights
January 13, 12:00 PM
Over the past 3 months, 11 analysts have published their opinion on CVS Health (NYSE:CVS) stock. These analysts…

CVS

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Morgan Stanley Maintains Overweight on CVS Health, Raises Price Target to $120

By Benzinga Newsdesk
January 13, 8:28 AM
Morgan Stanley analyst Erin Wright maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $119 to $120.

CVS

Read More
2 minute read
  • Long Ideas
  • Media
  • Top Stories
  • Trading Ideas

Why Disney, Boeing And CVS Are This Investor’s Top Stocks For 2023

By Adam Eckert
January 11, 5:59 PM
Sand Hill Global Advisors' Brenda Vingiello laid out her top stocks for 2023 Wednesday afternoon on CNBC's "Fast Money Halftime Report." Here's a look at her three best ideas for

BA

Read More
1 minute read
  • Markets
  • Media
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Jim Cramer Says Forget AT&T, This ‘Class Of The Field’ Communications Stock Is Better

By Lisa Levin
January 10, 9:24 AM
On CNBC’s "Mad Money Lightning Round," Jim Cramer said ADMA Biologics, Inc. (NASDAQ: ADMA) is a "great spec, but it is losing money hand over fist. I think it’s very binary.

ADMA

Read More
5 minute read
  • Biotech
  • General
  • Health Care
  • IPOs
  • Large Cap
  • M&A
  • Management
  • Markets
  • Media
  • News
  • Penny Stocks
  • Rumors
  • Tech
  • Top Stories

Coinbase Discloses Restructuring Plan Amid Macro Headwinds, Pfizer Rebuts Generic Version Of COVID-19 Oral Treatment In China, Microsoft Mulls $10B Investment In ChatGPT Owner: Today’s Top Stories

By Vandana Singh
January 10, 9:17 AM
Benzinga Coinbase Bows Down To Macro Headwinds, To Let Go Of 950 Employees

AAPL

Read More
4 minute read
  • Options

10 Health Care Stocks With Whale Alerts In Today’s Session

By Benzinga Insights
January 6, 1:36 PM
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

AMGN

Read More
1 minute read
  • Biotech
  • General
  • News

‘Aetna Considers A One-time Administration Of Elivaldogene Autotemcel (Skysona) Medically Necessary For Treatment Of Cerebral Adrenoleukodystrophy (Cald) When All Of The Following Criteria Are Met’ – Aetna

By Benzinga Newsdesk
January 5, 1:50 PM
https://www.aetna.com/cpb/medical/data/1000_1099/1017.html

BLUE

Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • News
  • Penny Stocks

Walgreens Boots Alliance Might Be First Pharmacy To Dispense Abortion Pills, Others To Follow

By Vandana Singh
January 5, 9:33 AM
Walgreens Boots Alliance Inc (NASDAQ:WBA) is reportedly the first major national pharmacy chain to say it plans to dispense…

CVS

Posts navigation

Previous 1 2 3 4 … 32 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service